
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+15
CytoGen, Inc. is a Circulating Tumor Cell (CTC) based Liquid Biopsy Platform company. We save lives and present relief enabling precision medicine, monitoring prognosis, early diagnosis assistance. The Liquid Biopsy Platform Smart BiopsyTM captures, stains, analyzes live CTC in the blood. - Smart BiopsyTM Cell Isolator CIS 030 - Smart BiopsyTM IF Stainer CST 030 - Smart BiopsyTM Cell Image Analyzer CIA 040 Our services are available at headquarters in Seoul, ExperTox CLIA Lab in Texas, CEPM branch in New York
Liquid biopsy,ctc isolation,companion diagnosis,cdx,live ctc,scrnaseq,ngs,cancer detection,minimal residual disease,mrd,patient enrichment,drug response monitoring,ctc,circulating tumor cell,ctc analysis,ctc liquid biopsy,cancer diagnosis,ctc separation,ctc capture,and ctc capture technology
Cytogen, inc operates in the Biotechnology research industry.
Cytogen, inc's revenue is 1m - 10m
Cytogen, inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.